Merck Closing 16 Sites, Including Two in United States
"Today's announcement is another important step as we successfully integrate our global operations on schedule and move forward with Merck's strategic priorities," said Richard T. Clark, chairman and CEO of Merck. "These changes are crucial to drive future growth and realize the promise of being a global healthcare leader for the long term. While we believe these actions are necessary to support Merck's competitive advantage, they required difficult decisions that will impact some of our colleagues, their families and local communities. We will implement our restructuring plans with the utmost care and respect for the hard-working and talented employees of Merck."
Merck expects that the consolidation will save the company $2.7 billion to $3.1 billion in 2012, just shy of its $3.5 billion cost-savings goal.
The company is closing research sites in Montreal and Cambridge, Massachusetts, along with others around the world. It will also shutter manufacturing plants in Miami Lakes, Florida, plus seven other global sites.
Overlook Produce and Farm Adventures Plans Rockingham County, Virginia, Produce Packing Hub
What’s Driving Record Industrial Real Estate Demand
2020 Top States for Doing Business Showcase Their Pro-Business Environments
2020 Gold & Silver Shovel Awards Recognize State and Local Economic Development Efforts
Pandemic Fuels Data Center Growth
Trends in Office and Industrial Parks
35th Annual Survey of Corporate Executives Commentary: Change in Site Selection Priorities and Plans Over the Short and Long Term